ExonHit Therapeutics Inc. Announces the Appointment of Its New Chief Financial Officer
PARIS--(BUSINESS WIRE)--Regulatory News: ExonHit Therapeutics (Paris:ALEHT) today announced the appointment of Hervé Duchesne de Lamotte as its Chief Financial Officer. Hervé Duchesne de Lamotte has over 25 years of international financial experience, including 10 years within the biotechnology industry.